Andro-Cyp 200 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Andro-Cyp 200
C
- C1 esterase inhibitor (human)
- calaspargase pegol
- calcipotriene topical
- calcipotriene / clobetasol topical
- calcipotriene / dimethicone topical
- Calcitrene (calcipotriene topical)
- calcitriol topical
- Calsodore (calcipotriene topical)
- Calsodore Kit (calcipotriene / dimethicone topical)
- Camzyos (mavacamten)
- cannabidiol
- Cardizem (diltiazem)
- Cardizem CD (diltiazem)
- Cardizem LA (diltiazem)
- Cardizem Monovial (diltiazem)
- Cardizem SR (diltiazem)
- carfilzomib
- Cartia XT (diltiazem)
- Celestone (betamethasone)
- Celestone Phosphate (betamethasone)
- Celestone Soluspan (betamethasone)
- Cell-U-Jec (betamethasone)
- cenobamate
- chlorpropamide
- Cinryze (C1 esterase inhibitor (human))
- Cinvanti (aprepitant)
- Clinacort (triamcinolone)
- Clinalog (triamcinolone)
- clofarabine
- Clolar (clofarabine)
- cobicistat / darunavir
- cobicistat / darunavir / emtricitabine / tenofovir alafenamide
- Colocort (hydrocortisone)
- conestat alfa
- conivaptan
- Contrave (bupropion / naltrexone)
- Copiktra (duvelisib)
- Cort-K (triamcinolone)
- Cortef (hydrocortisone)
- Cortenema (hydrocortisone)
- corticorelin
- corticotropin
- Cortifoam (hydrocortisone)
- cortisone
- Cortone Acetate (cortisone)
- Cortrosyn (cosyntropin)
- cosyntropin
- Cotolone (prednisolone)
- Coumadin (warfarin)
- Cresemba (isavuconazonium)
- cyclosporine
- Cytomel (liothyronine)
More about Andro-Cyp 200 (testosterone)
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.